OQROGet OQRO Pro
Insider trade

Lucid Diagnostics (LUCD)Director bought ~$172K

Dennis Matheis, Director at Lucid Diagnostics, bought ~$172K of Lucid Diagnostics shares.

~$172K
Approx. value · 130K sh @ $1.32
532K
Holds after · shares reported
Traded
May 21, 2025
Filed
May 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 20, 2025InsiderDirector purchased ~$242K of LUCD shares in the open market
  2. May 21, 2025 · this disclosureInsiderDirector purchased ~$172K of LUCD shares in the open market

What came next

  1. May 22, 2025InsiderDirector purchased ~$44K of LUCD shares in the open market
  2. Aug 20, 2025InsiderDirector purchased ~$102K of LUCD shares in the open market
  3. Sep 10, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lucid Diagnostics

OQRO holds no insider, Congress, fund or contract record for Lucid Diagnostics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LUCD page.

Other recent filings by Dennis Matheis, Director

The full history of Dennis Matheis, Director is on the profile page.

How this filing works

Other disclosures at Lucid Diagnostics

Everything OQRO holds on this company is on its LUCD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data